Format

Send to

Choose Destination
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Dec 3;63:76-82. doi: 10.1016/j.pnpbp.2015.05.004. Epub 2015 May 11.

Targeting drug sensitivity predictors: New potential strategies to improve pharmacotherapy of human brain disorders.

Author information

1
Research Institute for Marine Drugs and Nutrition, College for Food Science and Technology, Guangdong Ocean University, Zhanjiang, Guangdong 524025, China; ZENEREI Institute, 309 Palmer Court, Slidell, LA 70458, USA; Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia. Electronic address: avkalueff@gmail.com.
2
ZENEREI Institute, 309 Palmer Court, Slidell, LA 70458, USA.
3
Research Institute for Marine Drugs and Nutrition, College for Food Science and Technology, Guangdong Ocean University, Zhanjiang, Guangdong 524025, China.
4
Department of Psychology, University of Minnesota, Elliot Hall, Minneapolis, MN 55455, USA.

Abstract

One of the main challenges in medicine is the lack of efficient drug therapies for common human disorders. For example, although depressed patients receive powerful antidepressants, many often remain resistant to psychopharmacotherapy. The growing recognition of complex interplay between the drug targets and the predictors of drug sensitivity requires an improved understanding of these two key aspects of drug action and their potentially shared molecular networks. Here, we apply the concept of endophenotypes and their interplay to drug action and sensitivity. Based on these analyses, we postulate that novel drugs may be developed by targeting specific molecular pathways that integrate drug targets with drug sensitivity predictors.

KEYWORDS:

Drug sensitivity predictor; Drug target; Efficacy; Endophenotype; Psychopharmacotherapy

PMID:
25976211
DOI:
10.1016/j.pnpbp.2015.05.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center